ID

29735

Description

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00565539

Lien

https://clinicaltrials.gov/show/NCT00565539

Mots-clés

  1. 16/04/2018 16/04/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 avril 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis C, Chronic NCT00565539

Eligibility Hepatitis C, Chronic NCT00565539

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsed subjects (parts 1 and 2) -- prior treatment for hcv with peg-ifn-alpha (or other ifn-alpha) and ribavirin for at least 12 weeks. naive subjects (part 3) -- no prior treatment with peg-ifn-alpha (or other ifn-alpha)
Description

Recurrent disease | Prior Therapy Hepatitis C virus | peginterferon alfa-2a | peginterferon alfa-2b | Interferon-alpha | Ribavirin | Therapy naive

Type de données

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0220847
UMLS CUI [3]
C0391001
UMLS CUI [4]
C0796545
UMLS CUI [5]
C0002199
UMLS CUI [6]
C0035525
UMLS CUI [7]
C0919936
genotype 1 hcv rna greater than or equal to 100,000 iu/ml. mixed genotype hcv infection is not allowed
Description

Hepatitis C virus RNA assay HCV genotype determination

Type de données

boolean

Alias
UMLS CUI [1,1]
C1272251
UMLS CUI [1,2]
C1533728
documented liver biopsy ≤2 years of study enrollment with ishak score ≤4
Description

Biopsy of liver Ishak Score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0193388
UMLS CUI [1,2]
C2986945
no evidence of hepatocellular carcinoma documented by abdominal imaging within 12 months of study entry
Description

Absence Liver carcinoma Imaging of abdomen

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C2239176
UMLS CUI [1,3]
C2711454
no evidence of clinically significant diastolic or systolic dysfunction or other clinically significant abnormalities on echocardiogram or ecg
Description

Diastolic dysfunction Absent | Systolic dysfunction Absent | Echocardiogram normal | ECG normal

Type de données

boolean

Alias
UMLS CUI [1,1]
C0520863
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0749225
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0436484
UMLS CUI [4]
C0522054
negative drug and alcohol tests except for physician prescribed or approved medication
Description

Drug abuse test Negative | Alcohol use test Negative | Exception Drug Prescriptions

Type de données

boolean

Alias
UMLS CUI [1,1]
C0451130
UMLS CUI [1,2]
C1513916
UMLS CUI [2,1]
C0679532
UMLS CUI [2,2]
C1513916
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0033081
if male, or female of child-bearing potential, agrees to use 2 forms of medically accepted contraception while on study
Description

Gender Contraceptive methods Quantity | Childbearing Potential Contraceptive methods Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of decompensated liver disease
Description

Decompensated liver disease

Type de données

boolean

Alias
UMLS CUI [1]
C4075847
history of hypersensitivity to ifn-alpha or ribavirin
Description

Hypersensitivity Interferon-alpha | Hypersensitivity Ribavirin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0002199
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0035525
active substance abuse, such as alcohol, inhaled or injection drugs within the previous 6 months
Description

Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
undergone surgery or received blood products within 30 days prior to study enrollment
Description

Operative Surgical Procedures | Blood product Received

Type de données

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2,1]
C0456388
UMLS CUI [2,2]
C1514756
prior history of cardiomyopathy, coronary artery disease including angina, interventive procedure for coronary artery disease including angioplasty, stent procedure or cardiac bypass surgery, prior myocardial infarction, or ventricular tachycardia
Description

Cardiomyopathy | Coronary Artery Disease | Angina Pectoris | Interventional procedure Coronary Artery Disease | Angioplasty | Placement of stent | Coronary Artery Bypass Surgery | Myocardial Infarction | Tachycardia, Ventricular

Type de données

boolean

Alias
UMLS CUI [1]
C0878544
UMLS CUI [2]
C1956346
UMLS CUI [3]
C0002962
UMLS CUI [4,1]
C0184661
UMLS CUI [4,2]
C1956346
UMLS CUI [5]
C0162577
UMLS CUI [6]
C0522776
UMLS CUI [7]
C0010055
UMLS CUI [8]
C0027051
UMLS CUI [9]
C0042514
prior or current history of hemoglobinopathy or hemolytic anemia
Description

Hemoglobinopathy | Anemia, Hemolytic

Type de données

boolean

Alias
UMLS CUI [1]
C0019045
UMLS CUI [2]
C0002878

Similar models

Eligibility Hepatitis C, Chronic NCT00565539

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Recurrent disease | Prior Therapy Hepatitis C virus | peginterferon alfa-2a | peginterferon alfa-2b | Interferon-alpha | Ribavirin | Therapy naive
Item
relapsed subjects (parts 1 and 2) -- prior treatment for hcv with peg-ifn-alpha (or other ifn-alpha) and ribavirin for at least 12 weeks. naive subjects (part 3) -- no prior treatment with peg-ifn-alpha (or other ifn-alpha)
boolean
C0277556 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C0220847 (UMLS CUI [2,2])
C0391001 (UMLS CUI [3])
C0796545 (UMLS CUI [4])
C0002199 (UMLS CUI [5])
C0035525 (UMLS CUI [6])
C0919936 (UMLS CUI [7])
Hepatitis C virus RNA assay HCV genotype determination
Item
genotype 1 hcv rna greater than or equal to 100,000 iu/ml. mixed genotype hcv infection is not allowed
boolean
C1272251 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Biopsy of liver Ishak Score
Item
documented liver biopsy ≤2 years of study enrollment with ishak score ≤4
boolean
C0193388 (UMLS CUI [1,1])
C2986945 (UMLS CUI [1,2])
Absence Liver carcinoma Imaging of abdomen
Item
no evidence of hepatocellular carcinoma documented by abdominal imaging within 12 months of study entry
boolean
C0332197 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C2711454 (UMLS CUI [1,3])
Diastolic dysfunction Absent | Systolic dysfunction Absent | Echocardiogram normal | ECG normal
Item
no evidence of clinically significant diastolic or systolic dysfunction or other clinically significant abnormalities on echocardiogram or ecg
boolean
C0520863 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0749225 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0436484 (UMLS CUI [3])
C0522054 (UMLS CUI [4])
Drug abuse test Negative | Alcohol use test Negative | Exception Drug Prescriptions
Item
negative drug and alcohol tests except for physician prescribed or approved medication
boolean
C0451130 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
C0679532 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0033081 (UMLS CUI [3,2])
Gender Contraceptive methods Quantity | Childbearing Potential Contraceptive methods Quantity
Item
if male, or female of child-bearing potential, agrees to use 2 forms of medically accepted contraception while on study
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Decompensated liver disease
Item
evidence of decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Hypersensitivity Interferon-alpha | Hypersensitivity Ribavirin
Item
history of hypersensitivity to ifn-alpha or ribavirin
boolean
C0020517 (UMLS CUI [1,1])
C0002199 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Substance Use Disorders
Item
active substance abuse, such as alcohol, inhaled or injection drugs within the previous 6 months
boolean
C0038586 (UMLS CUI [1])
Operative Surgical Procedures | Blood product Received
Item
undergone surgery or received blood products within 30 days prior to study enrollment
boolean
C0543467 (UMLS CUI [1])
C0456388 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
Cardiomyopathy | Coronary Artery Disease | Angina Pectoris | Interventional procedure Coronary Artery Disease | Angioplasty | Placement of stent | Coronary Artery Bypass Surgery | Myocardial Infarction | Tachycardia, Ventricular
Item
prior history of cardiomyopathy, coronary artery disease including angina, interventive procedure for coronary artery disease including angioplasty, stent procedure or cardiac bypass surgery, prior myocardial infarction, or ventricular tachycardia
boolean
C0878544 (UMLS CUI [1])
C1956346 (UMLS CUI [2])
C0002962 (UMLS CUI [3])
C0184661 (UMLS CUI [4,1])
C1956346 (UMLS CUI [4,2])
C0162577 (UMLS CUI [5])
C0522776 (UMLS CUI [6])
C0010055 (UMLS CUI [7])
C0027051 (UMLS CUI [8])
C0042514 (UMLS CUI [9])
Hemoglobinopathy | Anemia, Hemolytic
Item
prior or current history of hemoglobinopathy or hemolytic anemia
boolean
C0019045 (UMLS CUI [1])
C0002878 (UMLS CUI [2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial